Literature DB >> 17105524

Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals.

Richelle J Cooper1, Malkeet Gupta, Michael S Wilkes, Jerome R Hoffman.   

Abstract

OBJECTIVE: We undertook this investigation to characterize conflict of interest (COI) policies of biomedical journals with respect to authors, peer-reviewers, and editors, and to ascertain what information about COI disclosures is publicly available.
METHODS: We performed a cross-sectional survey of a convenience sample of 135 editors of peer-reviewed biomedical journals that publish original research. We chose an international selection of general and specialty medical journals that publish in English. Selection was based on journal impact factor, and the recommendations of experts in the field. We developed and pilot tested a 3-part web-based survey. The survey included questions about the presence of specific policies for authors, peer-reviewers, and editors, specific restrictions on authors, peer-reviewers, and editors based on COI, and the public availability of these disclosures. Editors were contacted a minimum of 3 times.
RESULTS: The response rate for the survey was 91 (67%) of 135, and 85 (93%) of 91 journals reported having an author COI policy. Ten (11%) journals reported that they restrict author submissions based on COI (e.g., drug company authors' papers on their products are not accepted). While 77% report collecting COI information on all author submissions, only 57% publish all author disclosures. A minority of journals report having a specific policy on peer-reviewer 46% (42/91) or editor COI 40% (36/91); among these, 25% and 31% of journals state that they require recusal of peer-reviewers and editors if they report a COI. Only 3% of respondents publish COI disclosures of peer-reviewers, and 12% publish editor COI disclosures, while 11% and 24%, respectively, reported that this information is available upon request.
CONCLUSION: Many more journals have a policy regarding COI for authors than they do for peer-reviewers or editors. Even author COI policies are variable, depending on the type of manuscript submitted. The COI information that is collected by journals is often not published; the extent to which such "secret disclosure" may impact the integrity of the journal or the published work is not known.

Entities:  

Mesh:

Year:  2006        PMID: 17105524      PMCID: PMC1924760          DOI: 10.1111/j.1525-1497.2006.00598.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  14 in total

1.  The association between funding by commercial interests and study outcome in randomized controlled drug trials.

Authors:  J Yaphe; R Edman; B Knishkowy; J Herman
Journal:  Fam Pract       Date:  2001-12       Impact factor: 2.267

2.  Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Authors:  Niteesh K Choudhry; Henry Thomas Stelfox; Allan S Detsky
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

3.  Financial interests of authors in scientific journals: a pilot study of 14 publications.

Authors:  S Krimsky; L S Rothenberg; P Stott; G Kyle
Journal:  Sci Eng Ethics       Date:  1996-10       Impact factor: 3.525

4.  Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Authors:  Bodil Als-Nielsen; Wendong Chen; Christian Gluud; Lise L Kjaergard
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

5.  Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ.

Authors:  Lise L Kjaergard; Bodil Als-Nielsen
Journal:  BMJ       Date:  2002-08-03

6.  International Committee of Medical Journal Editors (ICMJE): Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication.

Authors: 
Journal:  Haematologica       Date:  2004-03       Impact factor: 9.941

7.  Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Authors:  Mohit Bhandari; Jason W Busse; Dianne Jackowski; Victor M Montori; Holger Schünemann; Sheila Sprague; Derek Mears; Emil H Schemitsch; Dianne Heels-Ansdell; P J Devereaux
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

8.  Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies.

Authors:  Phil B Fontanarosa; Annette Flanagin; Catherine D DeAngelis
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

9.  Conflict of interest in the debate over calcium-channel antagonists.

Authors:  H T Stelfox; G Chua; K O'Rourke; A S Detsky
Journal:  N Engl J Med       Date:  1998-01-08       Impact factor: 91.245

10.  Medical journals are an extension of the marketing arm of pharmaceutical companies.

Authors:  Richard Smith
Journal:  PLoS Med       Date:  2005-05-17       Impact factor: 11.069

View more
  26 in total

1.  Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.

Authors:  F Alfonso; A Timmis; F J Pinto; G Ambrosio; H Ector; P Kulakowski; P Vardas
Journal:  Neth Heart J       Date:  2012-06       Impact factor: 2.380

2.  Ethical issues in surgical research.

Authors:  Patrick J McDonald; Abhaya V Kulkarni; Forough Farrokhyar; Mohit Bhandari
Journal:  Can J Surg       Date:  2010-04       Impact factor: 2.089

3.  Is it time to standardize ethics guiding the peer review process?

Authors:  Francesca Bosetti; Christopher D Toscano
Journal:  Lipids       Date:  2007-11-29       Impact factor: 1.880

4.  Conflict of Interest and Funding Disclosure Policies of Environmental, Occupational, and Public Health Journals.

Authors:  David B Resnik; Brandon Konecny; Grace E Kissling
Journal:  J Occup Environ Med       Date:  2017-01       Impact factor: 2.162

5.  Transparent texts: authors of scientific articles often have conflicts of interest. It is important for these to be communicated transparently to the readers.

Authors:  Christopher Baethge
Journal:  Dtsch Arztebl Int       Date:  2008-10-03       Impact factor: 5.594

6.  Disclosures, conflict of interest, and funding issues in urogynecology articles: a bibliometric study.

Authors:  Marianne Koch; Paul Riss; Heinz Kölbl; Wolfgang Umek; Engelbert Hanzal
Journal:  Int Urogynecol J       Date:  2015-05-20       Impact factor: 2.894

7.  Conflict(s) of interest in peer review: its origins and possible solutions.

Authors:  Anton Oleinik
Journal:  Sci Eng Ethics       Date:  2013-01-05       Impact factor: 3.525

8.  Conflict of Interest in Journal Peer Review.

Authors:  David B Resnik; Susan A Elmore
Journal:  Toxicol Pathol       Date:  2018-01-30       Impact factor: 1.902

9.  Endoscope-assisted submandibular sialadenectomy: a review of outcomes, complications, and ethical concerns.

Authors:  Poramate Pitak-Arnnop; Niels Christian Pausch; Kittipong Dhanuthai; Kraison Sappayatosok; Pichit Ngamwannagul; Ute Bauer; Robert Sader; Alexander D Rapidis; Christian Hervé; Alexander Hemprich
Journal:  Eplasty       Date:  2010-05-21

10.  Taking financial relationships into account when assessing research.

Authors:  David B Resnik; Kevin C Elliott
Journal:  Account Res       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.